Peichl, P <br/><br/>
Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.  [electronic resource] 

 -  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology  Oct 2000 
 - 374-81 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0951-3590 
<br/><br/><label>Standard No.: </label>10.3109/09513590009167706  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Amino Acids--urine<br/>Biomarkers--blood<br/>Bone Resorption<br/>Collagen--urine<br/>Estrogen Replacement Therapy<br/>Estrogens--administration & dosage<br/>Female<br/>Follicle Stimulating Hormone--blood<br/>Humans<br/>Luteinizing Hormone--blood<br/>Middle Aged<br/>Norethindrone--administration & dosage<br/>Osteocalcin--blood<br/>Osteogenesis--drug effects<br/>Peptide Fragments--urine<br/>Postmenopause